Effects of IFNα on late stages of HIV-1 replication cycle

Biochimie

Volumn 80, Issue 8-9, 1998, Pages 745-754

  Dianzani, Ferdinando ^a   Castilletti, Concetta ^a   Gentile, Massimo ^a   Gelderblom, Hans R ^b   Frezza, Fabiola ^a   Capobianchi, Maria R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Assembly; Defective particles; HIV 1; Infectivity; Maturation

Indexed keywords

ALPHA INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; CD4 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; TARGET CELL; TRANSMISSION ELECTRON MICROSCOPY; VIRION; VIRUS ASSEMBLY; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032130973     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80028-5     Document Type: Article

References (54)

1. [1] Baron S., Dianzani F., The interferons: a biological system with therapeutic potential in virus infections, Antiviral Res 24 (1994) 97.
2. [2] Friedman R.M., Pitha P.M., The effect of interferon on membrane-associated viruses, in: Friedman R.M. (Ed.), Interferons Vol. 3: Mechanisms of Production and Action, Elsevier Science, B.V. North Holland Biomedical Press, Amsterdam, 1984,319 p.
3. [3] Pitha P.W., Wivel N.A., Fernie B.F., Harper H.P., Effect of interferon and murine leukemia virus infection. IV. Formation of non infectious virus in chronically infected cells, J. Gen. Virol. 42 (1979) 467.
4. [4] Pitha P.M., Rowe W.P., Oxman M.N., Effect of interferon on exogenous, endogenous, and chronic murine leukemia virus infection, Virology 70 (1976) 324.
5. [5] Dubrueil M., Sportza L., D'Addario M., Lacoste J., Rooke R., Wainberg M.A., Hiscott J., Inhibition of HIV-1 transmission by interferon and 3′-azido-3′-deoxythymidine during de novo infection of promonocytic cells, Virology 179 (1990) 388.
6. [6] Shirazy Y., Pitha P.M., Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle, J. Virol. 66 (1992) 1321.
7. [7] Shirazi Y., Pitha P.M., Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells, Virology 193 (1993) 303.
8. [8] Pitha P.M., Multiple effects of interferon on the replication of human immunodeficiency virus type 1, Antiviral Res. 24 (1994) 205.
9. [9] Macé K., Dodon M.D., Gazzolo L., Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha, Virology 168 (1988) 399.
10. [10] Sperber S.J., Gocke D.J., Haberzettl C., Kuk R., Schwartz B., Petska S., Anti-HIV-1 activity of recombinant and hybrid species of interferon alpha, J. Interferon Res. 12 (1992) 363.
11. [11] Wells D.E., Chatterjee S., Mulligan M.J., Compans R.W., Inhibition of human immunodeficiency virus type 1-induced cell fusion by recombinant human interferons, J. Virol. 65 (1991) 6325.
12. [12] Hartshorn K., Neumeyer D., Vogt M., Schooley R.T., Hirsh M.S., Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro, AIDS Res. Hum. Retroviruses 3 (1987) 125.
13. [13] Gendelman H.F., Baca L.M., Turpin J.A., Kalter D.C., Hansen B.D., Friedman R.M., Meltzer M.S., Restriction of HIV replication in infected T cells and monocytes by interferon-alpha, AIDS Res. Hum. Retroviruses 6 (1990) 1045.
14. [14] Kornbluth R.S., Oh, P.S., Munis J.R., Cleveland P.H., Richman D.D., Interferons and bacterial lipopolisaccharide protect macrophages, from productive infection by human immunodeficiency virus infection, J. Exp. Med. 169 (1989) 1137.
15. [15] Meyelan P.R., Guatelli J.C., Munis J.R., Richman D.D., Kornbluth R.S., Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages, Virology 193 (1993) 138.
16. [16] Yamada O., Hattori N., Kurimura T., Kita M., Kishida T., Inhibition of growth of HIV by human natural interferon in vitro, AIDS Res. Hum. Retroviruses 4 (1988) 287.
17. [17] Yamamoto J.K., Barré-Sinoussi F., Bolton V., Pedersen N.C., Gardner M.B., Human alpha-and beta-interferon but not gamma-suppresses the in vitro replication of LAV, HTLV-III and ARV-2, J. Interferon Res. 6 (1986) 143.
18. [18] Dolei A., Fattorossi A., D'Amelio R., Aiuti F., Dianzani F., Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III, J. Interferon Res. 6 (1986) 543.
19. [19] Poli G., Orenstein J.M., Kinter A., Folks T.M., Fauci A.S., Interferon alpha, but not AZT suppresses HIV expression in chronically infected cell lines, Science 244 (1989) 575.
20. [20] Fernie B.F., Poli G., Fauci A.S., Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected, T-lymphocytic cells, J. Virol. 65 (1991) 3968.
21. [21] Yasuda Y., Miyake S., Kato S., Kita M., Kishida T., Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1, J. AIDS 3 (1990) 1046.
22. [22] Crespi M., The effect of interferon on cells persistently infected with HIV, AIDS 3 (1989) 33.
23. [23] Smith M.S., Thresher R.J., Pagano J.S., Inhibition of human immuno-deficiency virus type 1 morphogenesis in T cells by alpha interferon, Antimicrob. Agents Chemother. 35 (1991) 62.
24. [24] Brinchmann J.E., Gaudernack N., Vartdal F., In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma or recombinant tumor necrosis factor-alpha, J. AIDS 4 (1991) 480.
25. [25] Poli G., Biswas P., Fauci A.S., Interferons in the pathogenesis and treatment of human immunodeficiency virus infection, Antiviral Res. 24 (1994) 221.
26. [26] Francis M.L., Meltzer M.S., Gendelman H.E., Interferon in the persistence, pathogenesis, and treatment of HIV infection, AIDS Res. Hum. Retroviruses 8 (1992) 199.
27. [27] Rivero J., Fraga M., Cancio I., Cuervo J., Mirò A., De Rosario M., Lopez-Saura P., Effect of interferon alpha (leukocyte or recombinant) on the survival of HIV-infected asymptomatic individuals, J. Interferon Res. 15 (1995) S228.
28. [28] Dianzani F., Capobianchi M.R., Interferon as a possible pathogenetic factor in HIV infection, Biotecnol. Appl. 14 (1997) 81.
29. [29] De Stefano E., Friedman R.M., Friedman-Kien A.E., Goedert J.J., Henriksen D., Preble O.T., Sonnabend J.A., Vilcek J., Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy, J. Infect. Dis. 146 (1982) 451.
30. [30] Preble O.T., Hook A.H. , Quinnan G.V. et al, Role of interferon in AIDS, Ann. N.Y. Acad. Sci. USA 437 (1984) 64.
31. [31] Buimovici-Klein E., Lange M., Klein R.J., Grieco M.H., Cooper L.Z., Long-term follow-up of serum interferon and its acid-stability in a group of homosexual men, AIDS Res. 2 (1989) 99.
32. [32] VonSydow M., Sonnerborg A., Gaines H., Strannegard O., Interferon α and tumor necrosis factor α in serum of patients in various stages of HIV-1 infection, AIDS Res. Hum. Retroviruses 7 (1991) 375.
33. [33] Rossol S., Voth R., Laubenstein H.P., Muller W.E.G., Meyer zum Buschenfelde K.H., Hess G., Interferon production in patients infected with HIV-1, J. Infect. Dis. 159 (1989) 815.-819
34. [34] Capobianchi M.R., De Marco F., DiMarco P., Dianzani F., Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells, Arch. Virol. 99 (1988) 9.
35. [35] Capobianchi M.R., Mattana P., Mercuri F., Conciatori G., Ameglio F., Ankel H., Dianzani F., Acid lability is not an intrinsic property of alpha-interferon induced by HIV-infected cells, J. Interferon Res. 12 (1992) 431.
36. [36] Capobianchi M.R., Ameglio F., Cordiali Fei P., Castillett I.C., Mercuri F. , Fais S. , Dianzani F., Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein gp120, AIDS Res. Hum. Retrovirus 9 (1993) 957.
37. [37] Ameglio F., Capobianchi M.R., Castilletti C., Cordiali Fei P., Fais S. , Trento E., Dianzani F., Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells. Correlation with the induction of other cytokines, Clin. Exp. Immunol. 95 (1994) 455.
38. [38] Castilletti C., Capobianchi M.R., Fais S., Abbate I., Ficociello B., Ameglio F., Cordiali Fei P., Santini S.M., Dianzani F., HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells, AIDS Res. Hum. Retrovirus 11 (1995) 547.
39. [39] Dianzani F., Antonelli G., Capobianchi M.R., DeMarco F., Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditions, Arch. Virol. 103 (1988) 127.
40. [40] Ankel H., Capobianchi M.R., Frezza F., Castilletti C., Dianzani F., Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids, Virology 221 (1996) 113.
41. [41] Fais S., Capobianchi M.R., Abbate I., Castilletti C., Gentile M., Cordiali Fei P., Ameglio F., Dianzani F., Unidirectional budding of HIV-1 at the site of the cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein, AIDS 9 (1995) 329.
42. [42] Gelderblom H.R., Hausmann E.H.S., Ozel M et al, Fine structures of human immunodeficiency virus (HIV) and immunolocalization of structural proteins, Virology 156 (1987) 171.
43. [43] Capobianchi M.R., Fais S., Castilletti C., Gentile M., Ameglio F., Dianzani F., A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus-1 particles, J. Infect. Dis. 169 (1994) 886.
44. [44] Hansen B., Nara P.L., Maheshwari R.K., Sidhu G.S., Bernbaum J.G., Hoekzema D., Meltzer M.S., Gendelman H.E., Loss infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120, J. Virol. 66 (1992) 7543.
45. [45] Babé L.M., Unal A., Craik C.S., Obstruction of HIV-1 particle release by interferon-α occurs before viral protease processing and is independent of envelope glycoprotein, J. Interferon Cytokine Res. 17 (1997) 287.
46. [46] Singh V.K., Maheshwari R.K., Damewood I.V.G.P. , Stephensen C.B., Oliver C., Friedman R.M., Interferon alters intracellular transport of vesicular stomatitis virus glycoprotein, J. Biol. Reg. Hom. Agents 2 (1992) 53.
47. [47] Lambert D.M., Petteway S.R., Jr, M.C Danal C.E., Hart T.K., Leary J.J., Dreyer G.B., Meek T.D., Bugelski P.J., Bolognesi D.P., Metcalf B.W., Matthews T.J., Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells, Antimicrib. Agents Chemiother. 36 (1992) 982.
48. [48] Schatzl H., Gelderblom H.R., Nischko H., VonDer Helm K., Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor, Arch. Virol. 120 (1991) 71.
49. [49] Rizzuto C.D., Sodroski J.C., Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensivivity to neutralization, J. Virol. 71 (1997) 4847.
50. [50] Coccia E.M., Krust B., Hovanessian A., Specific inhibition of protein synthesis in HIV-infected cels in response to interferon tretment, J. Biol. Chem. 269 (1994) 23087.
51. [51] Kunzi M.S., Farzadegan H., Margolick J.B., Vlahov D., Pitha P., Identification of human immunodeficiency virus primary isolates resistant to IFN-alpha and correlation of prevalence to disease progression, J. Infect. Dis. 171 (1995) 822.
52. [52] Chirmule N., Pahwa S., Envelope glycoprotein of human immunodeficiency virus type 1: profound influences on immune functions, Microbiol. Rev. 60 (1996) 386.
53. [53] Capobianchi M.R., Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis, J. Biol. Regul. Homeostatic Agents 4 (1997) 83.
54. [54] Dianzani F., Scheglovitova O., Gentile M., Scanio V., Barresi C., Ficociello B., Bianchi F., Fiumara D., Capobianchi M.R., Interferon gamma stimulates cell-mediated transmission of HIV-type 1 from abortively infected endothelial cells, AIDS Res. Hum. Retroviruses 12 (1996) 621.